Product Information

FEBUXOSTAT 80 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.2502 per EA under NDC 00527224832. Its NADAC has been published 212 times since Oct 26, 2022.

FDA first approved this application on Jun 2, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FEBUXOSTAT 80 MG TABLET

febuxostat
$0.2502per EA

Strength

80 mg/1

NDC

00527224832

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

FEBUXOSTAT

Approval Type

Generic (ANDA)

FDA Application

ANDA213069

FDA Approved

6/2/2020

TE Code

AB

On Market Since

6/2/2020

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for FEBUXOSTAT 80 MG TABLET has been published 212 times since Oct 26, 2022, and over the history we have for it it has declined 70.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2502 per EA
All-time high$0.8512 (Nov 16, 2022)
All-time low$0.2502 (Oct 21, 2026)
52-week high$0.3536
52-week low$0.2502
Median price$0.4758
Average price$0.4893
Largest weekly change+46.7% (Feb 22, 2023)
Weeks tracked212
Tracking sinceOct 26, 2022

Price History

1W

0.0%

1M

-4.2%

3M

-20.8%

6M

-24.1%

1Y

-26.2%

3Y

-61.3%

5Y

N/A

All

-70.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FEBUXOSTAT 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Lannett Company Inc., is $0.2502 per EA (NDC 00527224832), effective Nov 11, 2026.

How has the price of FEBUXOSTAT 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 70.6%. It has been tracked across 212 weekly CMS publications since Oct 26, 2022.

What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?

Since Oct 26, 2022, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2502 (Oct 21, 2026) to a high of $0.8512 (Nov 16, 2022), with a median of $0.4758 per EA.

Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEBUXOSTAT 80 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FEBUXOSTAT 80 MG TABLET?

FEBUXOSTAT 80 MG TABLET (NDC 00527224832) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.